Tests for lifetime utility or cost via calibrating survival time

Statistica Sinica

Volumn 12, Issue 3, 2002, Pages 707-723

  Huang, Yijian ^a   Lovato, Laura ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Accelerated failure time model; Dependent censoring; Estimating equation; Identifiability; Lifetime medical cost; Log rank statistic; Marked point process; Minimum dispersion statistic; Optimization; Pitman efficiency

Indexed keywords

EID: 0036660773     PISSN: 10170405     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Andersen, P.K., Borgan, O., Gill, R.D. and Keiding, N. (1993). Statistical Models Based on Counting Processes. Springer-Verlag, New York.
2. Bang, H. and Tsiatis, A.A. (2000). Estimating medical costs with censored data. Biometrika 87, 329-343.
3. Genest, C. (1987). Frank's family of bivariate distributions. Biometrika 74, 549-555.
4. Gill, R.D. and Schumacher, M. (1987). A simple test of the proportional hazards assumption. Biometrika 74, 289-300.
5. Glasziou, P.P., Simes, R.J. and Gelber, R.D. (1990). Quality adjusted survival analysis. Statist. Med. 9, 1259-1276.
6. Huang, Y. (1999). The two-sample problem with induced dependent censorship. Biometrics 55, 1108-1113.
7. Huang, Y. and Louis, T.A. (1998). Nonparametric estimation of the joint distribution of survival time and mark variables. Biometrika 85, 785-798.
8. Huang, Y. and Louis, T.A. (1999). Expressing estimators of expected quality adjusted survival as functions of Nelson-Aalen estimators. Lifetime Data Anal. 5, 199-212.
9. Kalbfleisch, J.D. and Prentice, R.L. (1980). The Statistical Analysis of Failure Time Data. Wiley, New York.
10. Kelly, K., Crowley, J., Bunn, P.A., Jr., Presant, C.A., Grevstad, P.K., Moinpour, C.M., Ramsey, S.D., Wozniak, A.J., Weiss, G.R., Moore, D.F., Israel, V.K., Livingston, R.B. and Gandara, D.R. (2001). Randomized phase III trial of Paclitaxel plus Carboplatin versus Vinorelbine plus Cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group Trial. J. Clin. Oncol. 19, 3210-3218.
11. Lai, T.L. and Ying, Z. (1988). Stochastic integrals of empirical-type processes with applications to censored regression. J. Mult. Anal. 27, 334-358.
12. Lin, D.Y. (2000a). Linear regression analysis of censored medical costs. Biostatistics 1, 35-47.
13. Lin, D.Y. (2000b). Proportional means regression for censored medical costs. Biometrics 56, 775-778.
14. Lin, D.Y., Feuer, E.J., Etzioni, R. and Wax Y. (1997). Estimating medical costs from incomplete follow-up data. Biometrics 53, 419-434.
15. Louis, T.A. (1981). Nonparametric analysis of an accelerated failure time model. Biometrika 68, 381-390.
16. Wei, L.J. and Gail, M.H. (1983). Nonparametric estimation for a scale-change with censored observations. J. Am. Statist. Assoc. 78, 382-388.
17. Wei, L.J., Ying, Z. and Lin, D.Y. (1990). Linear regression analysis of censored survival data based on rank tests. Biometrika 77, 845-851.
18. Yang, S. (1998). Some scale estimators and lack-of-fit tests for the censored two sample accelerated life model. Biometrics 54, 1040-1052. Correction, 56, 324.
19. Zhao, H. and Tsiatis, A.A. (1997). A consistent estimator for the distribution of quality adjusted survival time. Biometrika 84, 339-348.
20. Zhao, H. and Tsiatis, A.A. (2000). Estimating mean quality adjusted lifetime with censored data. Sankhya Ser. B 62, 175-188.
21. Zhou, X.-H., Melfi, C.A. and Hui, S.L. (1997). Methods for comparison of cost data. Ann. Intern. Med. 127, 752-756.